Generative AI in Healthcare Market Projected to Hit $21.6B by 2034
Event summary
- The global generative AI in healthcare market was valued at $1.84B in 2024 and is expected to reach $21.64B by 2034, growing at a CAGR of 31.4%.
- Medical imaging & diagnostics led the market due to FDA-cleared tools improving accuracy and speed.
- Healthcare providers dominated the end-use segment with around a 47% share, driven by hospital IT procurement for workflow optimization.
- Cloud-based deployment held approximately a 68% share due to scalability advantages.
The big picture
The generative AI in healthcare market is poised for rapid growth driven by physician burnout, clinically validated performance in imaging and drug discovery, and surging investments. However, regulatory burdens, data privacy concerns, and risks such as AI hallucination may limit expansion. The market's dominance in North America highlights the region's advanced infrastructure and high investment, while opportunities arise from healthcare-specific models and payer automation.
What we're watching
- Regulatory Hurdles
- Whether stringent FDA and EU AI Act requirements will slow down market expansion due to high compliance costs.
- Technological Advancements
- The pace at which healthcare-specific foundation models will unlock new growth avenues through superior performance in medical reasoning.
- Market Expansion
- How emerging markets like Asia Pacific will drive significant expansion possibilities for scalable, cloud-native solutions.
Related topics